Health Observer Falkland Islands: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Observer Falkland Islands.

September 2025

Mo	Tu	We	Th	Fr	Sa	Su
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

October 2025

Mo	Tu	We	Th	Fr	Sa	Su
		1	2	3	4	5
6	7	8	9	10	11	12
13	14	15	16	17	18	19
20	21	22	23	24	25	26
27	28	29	30	31

November 2025

Mo	Tu	We	Th	Fr	Sa	Su
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

Press releases published on November 7, 2025

November 7, 2025

Ursolic Acid Market Forecasted to Achieve US $0.02 Billion by 2029

EIN Presswire

November 7, 2025

Adsorbents Market Projected to Witness a Growth of US $6.91 Billion by 2029 | The Business Research Company

EIN Presswire

November 7, 2025

Inpatient Services Market Expected To Reach USD 2.52 Tn 2032, Industry Analysis & Forecast 2025–2032

EIN Presswire

November 7, 2025

Acne Treatment Market To Reach USD 20.46 Billion by 2032, at a CAGR of 6.2%. Industry Analysis and Forecast 2025-2032

EIN Presswire

November 7, 2025

Wave Life Sciences to Present at Upcoming Investor Conferences

GlobeNewswire

November 7, 2025

Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th

GlobeNewswire

November 7, 2025

New Pooled 3-Year Analysis Confirms Sustained, Clinically Meaningful Improvements in Renal Function for TransCon® PTH (Palopegteriparatide)-Treated Adults with Hypoparathyroidism

GlobeNewswire

November 7, 2025

ALX Oncology Reports Third Quarter 2025 Financial Results and Provides Corporate Update

GlobeNewswire

November 7, 2025

Treace Announces Participation in Two Upcoming Investor Conferences

GlobeNewswire

November 7, 2025

IMUNON R&D Day: Opportunity to Hear Clinical Trial Investigators Discuss Significant Potential of IMNN-001 to Redefine Ovarian Cancer Treatment

GlobeNewswire

November 7, 2025

Altimmune Presents AI-Based Analysis of Liver Fibrosis Reduction from IMPACT Phase 2b Trial of Pemvidutide in MASH in Late-breaking Poster at AASLD The Liver Meeting® 2025

GlobeNewswire

November 7, 2025

Celldex to Present at Upcoming Investor Conferences

GlobeNewswire

November 7, 2025

Immunocore presents Phase 1 data for hepatitis B candidate at AASLD’s The Liver Meeting

GlobeNewswire

November 7, 2025

Press Release: ACAAI: Sanofi and Regeneron’s Dupixent pivotal study met all primary and secondary endpoints, reducing signs and symptoms of allergic fungal rhinosinusitis; sBLA accepted for FDA priority review

GlobeNewswire

November 7, 2025

Communiqué de presse : ACAAI : L’étude pivot Dupixent menée par Sanofi et Regeneron a atteint l’ensemble de ses critères d’évaluation principaux et secondaires, réduisant les signes et symptômes de la rhinosinusite fongique allergique...

GlobeNewswire

November 7, 2025

Dr. Adrian Bot joins Immuthera to support the company with his unique experience in commercialization of groundbreaking cell therapies

GlobeNewswire

November 7, 2025

Vor Bio to Participate in Upcoming Investor Conferences

GlobeNewswire

November 7, 2025

Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences

GlobeNewswire

November 7, 2025

Assembly Biosciences Presents Positive Phase 1b Data for Next-Generation Capsid Assembly Modulator ABI-4334 at AASLD The Liver Meeting®

GlobeNewswire

November 7, 2025

Atea Pharmaceuticals Presents New Data Supporting the Fixed-Dose Combination of Bemnifosbuvir and Ruzasvir as a Potential Best-in-Class Regimen for Treatment of Hepatitis C Virus Infection at The Liver Meeting® 2025

GlobeNewswire